For example: Apple Inc, UTIL, Aluminum
Fortress Biotech Inc
NASDAQ:FBIO
Market Close 11/27
2.77 USD +0.16 (+6.13%)
OPEN:
2.61
DAY RANGE:
2.61 - 2.82
PE:
-1.29
PB:
26.32
PS:
-1.05
WTD % -2.12
MTD % 25.91
QTD % -31.44
YTD % 7.78
* Updated at market close
Fortress Biotech Inc (NASDAQ:FBIO) opened on Nov 27, 2020 at 2.61 USD and rallied 6.13%. The intraday price range was 2.61 - 2.82 USD and eventually ended the session at 2.77 USD. The stock trade volume was 398,100.00 shares. The company's 52-week range is 1.04 - 4.78 USD.
Trading Statistics (Market Close Nov 27, 2020)
Market Cap 243.78 M
Outstanding Stock 56.68 M
Dividend 0.00
Dividend Yield 0.00
EPS -1.16
YTD Change 7.78%
52 Week's Range 1.04 - 4.78
Key Ratio & Margins (Market Close Nov 27, 2020)
Price/Earning -1.29
Price/Book Value 26.32
Price/Sales -1.05
ROA -
ROE -
Debt/Equity 4.31
Company Self Description
Fortress Biotech, Inc. develops and commercializes pharmaceutical and biotechnology products. The company develops CNDO-109, a lysate that treats cancer-related and other conditions; tramadol HCl for managing postoperative pain; CAEL-101 for the treatment of amyloid light chain amyloidosis; and CEVA101 for severe traumatic brain injury in children and adults in the United States and also develops CK-301 for treating patients with non-small cell lung cancer (NSCLC); CK-101 for the treatment of patients with epidermal growth factor receptor mutation-positive NSCLC; and antibodies that target glucocorticoid-induced TNFR-related protein and carbonic anhydrase IX. It was founded in 2006 and is based in New York, New York, United States.
Business Information
Fortress Biotech Inc
Sector Health Care
Industry Biotechnology
Exchange NASDAQ
Top Competitors (Market Close Nov 27, 2020)
  FBIO CHMA EVLO PSTI
Daily Change (%) 6.13 0.24 0.19 2.90
WTD (%) -2.12 6.50 8.79 4.24
MTD (%) 25.91 13.60 30.98 3.34
QTD (%) -31.44 -0.93 -1.33 -9.02
YTD (%) 7.78 -14.11 28.08 143.15
52-Week Change (%) 40.61 -21.83 5.91 176.08
Stock Performance (Market Close Nov 27, 2020)
  FBIO CHMA EVLO PSTI
Daily Change (%) 6.13 0.24 0.19 2.90
WTD (%) -2.12 6.50 8.79 4.24
MTD (%) 25.91 13.60 30.98 3.34
QTD (%) -31.44 -0.93 -1.33 -9.02
YTD (%) 7.78 -14.11 28.08 143.15
52-Week Change (%) 40.61 -21.83 5.91 176.08
Key Fundamentals (Market Close Nov 27, 2020)
  FBIO CHMA EVLO PSTI
Market Cap 243.78 M 246.24 M 239.91 M 244.81 M
Revenue Growth - - - -
Net Income Growth - - - -
Profit Margin 69.40% 0.00 0.00 -73,056.00%
P/E Ratio -1.29 -5.98 -4.24 -2.94
Price to Sales Ratio -1.05 0 0 2,274.18
Price to Book Ratio 26.32 2.23 3.02 4.75
Enterprise Value to EBITDA -0.27 -2.08 -6.51 -4.06
ROA - -56.00% -48.10% -129.40%
ROE - -84.10% -57.30% -197.80%
Debt/Equity 4.31 0.85 0.17 0.37
Asset Turnover Ratio -0.39 0 0 0.00
Current Ratio 2.00 2.17 16.42 3.75
Dividend Yield 0.00 0 0 0
in USD
  Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015
Revenue 26.88 M 17.25 M 16.48 M 863,000.00
Cost Of Revenue 6.13 M 3.66 M 790,000.00 0.00
Gross Profit 20.76 M 13.59 M 15.69 M 863,000.00
Selling General & Administrative Expenses 53.37 M 50.90 M 34.51 M 21.58 M
Research & Development 87.38 M 52.49 M 35.13 M 29.81 M
Operating Income -120.00 M -89.80 M -65.71 M -50.53 M
Net Income -84.15 M -66.88 M -55.10 M -48.43 M
EPS -1.94 -1.61 -1.38 -1.24
Diluted EPS -1.94 -1.61 -1.38 -1.24
  Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018
Revenue 9.25 M 6.48 M -156.07 M 63.69 M
Cost Of Revenue 2.39 M 1.88 M 1.58 M 1.41 M
Gross Profit 6.86 M 4.59 M -157.65 M 62.29 M
Selling General & Administrative Expenses 13.44 M 13.48 M 5.68 M 14.69 M
Research & Development 18.71 M 23.72 M 25.05 M 19.79 M
Operating Income -25.29 M -32.61 M -35.06 M -24.86 M
Net Income -13.10 M 1.39 M -24.88 M -16.64 M
EPS -0.24 0.03 -0.58 -0.37
Diluted EPS -0.24 0.02 -0.58 -0.37
in USD
  Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015
Total Current Assets 111.21 M 183.18 M 109.63 M 99.94 M
Cash & Cash Equivalents 81.58 M 110.96 M 104.15 M 112.77 M
Total Assets 140.99 M 245.95 M 170.73 M 118.61 M
Total Current Liabilities 55.61 M 71.44 M 56.57 M 10.58 M
Total Liabilities 121.25 M 125.45 M 87.76 M 34.34 M
Shareholder's Equity 1.85 M 52.57 M 38.50 M 56.85 M
Outstanding Stock 56.68 M 50.66 M 48.88 M 47.13 M
  Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018
Total Current Assets 163.51 M 136.55 M 111.21 M 159.52 M
Cash & Cash Equivalents 165.48 M 132.52 M 81.58 M 113.23 M
Total Assets 227.26 M 200.54 M 140.99 M 224.92 M
Total Current Liabilities 36.40 M 48.96 M 55.61 M 70.78 M
Total Liabilities 137.44 M 149.83 M 121.25 M 140.28 M
Shareholder's Equity 31.87 M 20.82 M 1.85 M 37.77 M
Outstanding Stock 65.23 M 61.30 M 56.68 M 54.35 M
in USD
  Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015
Net Cash Flow from Operations -98.85 M -81.31 M -45.81 M -20.38 M
Capital Expenditures -7.08 M -648,000.00 -6.37 M -283,000.00
Net Cash Flow from Investing Activities 18.82 M -40.22 M -6.06 M 7.89 M
Net Cash Flow from Financial Activities 50.65 M 150.38 M 42.91 M 60.92 M
Free Cash Flow -105.93 M -81.95 M -52.18 M -20.66 M
  Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018
Net Cash Flow from Operations -28.32 M -81.31 M -45.81 M -20.38 M
Capital Expenditures -655,000.00 -300,000.00 -254,000.00 -2.17 M
Net Cash Flow from Investing Activities -611,000.00 24.15 M 13.77 M 9.32 M
Net Cash Flow from Financial Activities 61.89 M 52.11 M -3.35 M 9.96 M
Free Cash Flow -28.98 M -25.63 M -21.27 M -24.70 M
Key Ratios (Market Close Nov 27, 2020)
Valuation Ratios 2020 2019 2018 2017
P/E Ratio -1.29 -1.25 -0.44 -1.01
Price to Sales Ratio -1.05 -1.09 1.39 -1.48
Price to Book Ratio 26.32 3.85 3.43 2.31
Enterprise Value to EBIT 0.00 -2.00 -1.00 -2.00
Enterprise Value to EBITDA -0.27 -2.37 -1.21 -2.44
Profitability Ratios 2020 2019 2018 2017
Revenue Growth - - - -
Net Income Growth - - - -
ROA - - -38.80% -28.10%
ROE - - -268.80% -127.70%
Liquidity Ratios 2020 2019 2018 2017
Working Capital 55.59 M 111.74 M 53.07 M 89.36 M
Current Ratio 2.00 2.56 1.94 9.45
Efficiency & Capital Structure Ratios 2020 2019 2018 2017
Debt Equity Ratio 4.31 2.39 2.28 0.60
Asset Turnover Ratio - - 0.12 0.07
Scratchpad (max of 30 tickers)
Symbol Last Price Change
Empty Scratchpad
Portfolio (max of 30 tickers)
Login is required to view your portfolio.